Company Filing History:
Years Active: 1992-1995
Title: Maan Zrein: Innovator in Peptide Research
Introduction
Maan Zrein is a notable inventor based in Laval, Canada. He has made significant contributions to the field of peptide research, holding a total of 4 patents. His work focuses on developing innovative solutions for detecting viral infections, particularly those related to rubella and HTLV.
Latest Patents
One of Maan Zrein's latest patents is titled "Peptides, analogues and mixtures thereof for detecting and eliciting." This invention discloses linear and cyclic peptides of the E1 and E2 glycoproteins of the rubella virus. These peptides and their analogues are instrumental in detecting and quantifying antibodies raised against the rubella virus. They also play a crucial role in raising antibodies for the diagnosis and protection against rubella viral infections. Another significant patent is "Peptides and analogues and mixtures thereof for detecting antibodies to." This invention relates to novel linear peptides and chemical combinations useful for detecting and quantifying HTLV-I and HTLV-II infections. These peptides are also beneficial in developing vaccines against HTLV-I and HTLV-II viral infections.
Career Highlights
Throughout his career, Maan Zrein has worked with various companies, including Biochem Immunosystems Inc. and Iaf Biochem International, Inc. His expertise in peptide research has positioned him as a valuable asset in the biotechnology sector.
Collaborations
Maan has collaborated with notable individuals in his field, including Martial Lacroix and Gervais Dionne. Their combined efforts have contributed to advancements in peptide technology and its applications in medical diagnostics.
Conclusion
Maan Zrein's innovative work in peptide research has led to significant advancements in the detection of viral infections. His contributions continue to impact the field positively, showcasing the importance of innovation in biotechnology.